Parametric Risk Advisors’s Allergan plc AGN Stock Holding History

Parametric Risk Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,000	Closed	-$3.47M	–	134
2016 Q2	$3.47M	Buy	+15,000	New	+$3.46M	0.23%	66
2015 Q4	–	Sell	-15,000	Closed	-$4.08M	–	121
2015 Q3	$4.08M	Hold	15,000	–	–	0.26%	45
2015 Q2	$4.55M	Hold	15,000	–	–	0.3%	48
2015 Q1	$4.46M	Buy	15,000 +5,000	+50%	+$1.43M	0.3%	47
2014 Q4	$2.57M	Buy	10,000 +2,500	+33%	+$625K	0.17%	75
2014 Q3	$1.81M	Buy	7,500 +2,500	+50%	+$559K	0.12%	86
2014 Q2	$1.11M	Hold	5,000	–	–	0.07%	99
2014 Q1	$1.03M	Buy	+5,000	New	+$990K	0.07%	101

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Parametric Risk Advisors's AGN Position: Q3 2016 in Review

Parametric Risk Advisors sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 15,000 shares — an estimated $3.47M sold.

Parametric Risk Advisors first reported a position in AGN in Q1 2014 and held it in 8 quarters. The position peaked at $4.55M in Q2 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

Parametric Risk Advisors reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
Parametric Risk Advisors sold 15,000 Allergan plc shares in Q3 2016, an estimated $3.47M.
Parametric Risk Advisors first reported a position in Allergan plc in Q1 2014 and held it in 8 quarters.
Parametric Risk Advisors's Allergan plc position peaked at $4.55M in Q2 2015.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Parametric Risk Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.